Kavita Batra (Medicine), in collaboration with Jagdish Khubchandani (New Mexico State University), Ravi Batra (Public Health), and Syed Aman Ali (Jinnah Postgraduate Medical Centre, Pakistan) published "Psychiatric Safety of GLP-1 Receptor Agonists Across Type 2 Diabetes and Obesity: An Integrative Review" in Diabetology. The review synthesizes evidence from clinical trials, observational studies, pharmacovigilance data, and regulatory evaluations to assess the neuropsychiatric safety of GLP-1 receptor agonists. The authors conclude that current evidence does not support a causal association between GLP-1 receptor agonists and suicidality or major psychiatric harm in the general treated population, while emphasizing the importance of individualized monitoring for patients with pre-existing psychiatric conditions.